Literature DB >> 15043198

Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases.

Martine P Roudier1, Eva Corey, Lawrence D True, Celestia S Hiagno, Susan M Ott, Robert L Vessell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15043198     DOI： 10.1007/978-1-4419-9129-4_13

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  18 in total

1.  Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone.

Authors:  Olga Zolochevska; Jayne Ellis; Sangram Parelkar; Delphine Chan-Seng; Todd Emrick; Jingna Wei; Igor Patrikeev; Massoud Motamedi; Marxa L Figueiredo
Journal:  Hum Gene Ther       Date:  2013-11-06       Impact factor: 5.695

2.  Non-invasive microCT imaging characterization and in vivo targeting of BB2 receptor expression of a PC-3 bone metastasis model.

Authors:  Christopher T Winkelmann; Said Daibes Figueroa; Gary L Sieckman; Tammy L Rold; Timothy J Hoffman
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

3.  p21CIP-1/WAF-1 induction is required to inhibit prostate cancer growth elicited by deficient expression of the Wnt inhibitor Dickkopf-1.

Authors:  Christopher L Hall; Honglai Zhang; Shobun Baile; Mats Ljungman; Stuart Kuhstoss; Evan T Keller
Journal:  Cancer Res       Date:  2010-11-23       Impact factor: 12.701

Review 4.  Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases.

Authors:  Thomas J Wilson; Rakesh K Singh
Journal:  Biochim Biophys Acta       Date:  2007-11-26

Review 5.  The role of the microenvironment-dormant prostate disseminated tumor cells in the bone marrow.

Authors:  Hung-Ming Lam; Robert L Vessella; Colm Morrissey
Journal:  Drug Discov Today Technol       Date:  2014-03

6.  AFM-based dual nano-mechanical phenotypes for cancer metastasis.

Authors:  Soyeun Park; Yong J Lee
Journal:  J Biol Phys       Date:  2014-06-30       Impact factor: 1.365

7.  Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance.

Authors:  Hung-Ming Lam; Holly M Nguyen; Eva Corey
Journal:  Methods Mol Biol       Date:  2018

8.  Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells.

Authors:  Danielle McKeithen; Tisheeka Graham; Leland W K Chung; Valerie Odero-Marah
Journal:  Prostate       Date:  2010-06-15       Impact factor: 4.104

9.  Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.

Authors:  Colm Morrissey; Lawrence D True; Martine P Roudier; Ilsa M Coleman; Sarah Hawley; Peter S Nelson; Roger Coleman; Ya-Chun Wang; Eva Corey; Paul H Lange; Celestia S Higano; Robert L Vessella
Journal:  Clin Exp Metastasis       Date:  2007-10-31       Impact factor: 5.150

10.  PTHrP contributes to the anti-proliferative and integrin alpha6beta4-regulating effects of 1,25-dihydroxyvitamin D(3).

Authors:  Xiaoli Shen; Ramanjaneya V R Mula; Jing Li; Nancy L Weigel; Miriam Falzon
Journal:  Steroids       Date:  2007-08-15       Impact factor: 2.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.